Metabolic Syndrome and Benign Prostatic Hyperplasia/What Component of Metabolic Syndrome Is Related to Benign Prostatic Hyperplasia?
| Autor: | Tarım, Bahar Arıcan, Çamur, Emre, Kavukoğlu, Övünç, Kösemen, Mete, Özgür, Yasemin, Narter, Kamil Fehmi |
|---|---|
| Předmět: |
METABOLIC syndrome risk factors
TRIGLYCERIDES RESEARCH OBESITY SCIENTIFIC observation INTERNAL medicine HYPERGLYCEMIA URINARY tract infections INFLAMMATION CROSS-sectional method BENIGN prostatic hyperplasia RISK assessment HYPERLIPIDEMIA DESCRIPTIVE statistics STATISTICAL correlation DISEASE risk factors DISEASE complications |
| Zdroj: | Journal of Urological Surgery; Sep2023, Vol. 10 Issue 3, p194-198, 5p |
| Abstrakt: | Objective: Our objective was to evaluate the association of benign prostatic hyperplasia (BPH) with each component of metabolic syndrome (MS), and determine which component plays the major risk for developing BPH. Materials and Methods: This cross-sectional observational study was performed on 203 male patients aged over 50, who came to the internal medicine outpatient clinics just for a check-up with/without any known disease. Forty-three of them were healthy control patients and the rest had only 1 criterion of MS. They were searched for the presence of BPH. Results: BPH prevalence ranged between 45.5-65.6% in the subgroups, there was no statistically significant difference in the presence of BPH between these groups. There was a slight positive correlation between glucose level and prostate volume. Triglyceride levels were positively correlated with Q |
| Databáze: | Complementary Index |
| Externí odkaz: |
|